An interventional study of Blood Collection in Autosomal Dominant Polycystic Kidney Disease (ADPKD), sponsored by University Hospital, Brest. Completed at 25 sites in France. Open to participants aged 16 Years and older. Per ClinicalTrials.gov, last updated 2021-03-24.
Sponsored by University Hospital, Brest · Not applicable, Interventional, and Diagnostic
The aim of this study is to identify families with ADPKD , characterize the phenotype and screen for mutations in known genes (PKD1 and PKD2, and then HNF1b and UMOD in PKD1 PKD2 negative carriers).
Genome wide analysis will be performed in families without mutations identified.
Inclusion Criteria for the proband :
Inclusion Criteria of the relatives (affected or non affected) :
Exclusion Criteria for the Probands:
Exclusion criteria for the Relatives:
* No drug will be administrated in this study * Blood collection
Other: Blood Collection
Phenotype and Genotype Analysis, Biological Analysis
Number of patients/families with no mutations identified in PKD1 and PKD2 genes
Time frame: 3 years
Plan to share: Yes — All collected data that underlie results in a publication
Supporting information: Study protocol
This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Hospital, Brest